Related references
Note: Only part of the references are listed.Impact of Tyrosine Kinase Inhibitors on the Incidence of Brain Metastasis in Metastatic Renal Cell Carcinoma
Jonathan Verma et al.
CANCER (2011)
Phase II study of sunitinib malate in patients with recurrent high-grade glioma
B. Neyns et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma
David A. Reardon et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Bevacizumab for Recurrent Glioblastoma Multiforme: A Meta-Analysis
Eric T. Wong et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2011)
Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
Wolfgang Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib
Manik Chahal et al.
NEURO-ONCOLOGY (2010)
NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
Wolfgang Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
Teri N. Kreisl et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Salvage chemotherapy with bevacizumab for recurrent alkylator-refractory anaplastic astrocytoma
Marc C. Chamberlain et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model
Qingyu Zhou et al.
NEURO-ONCOLOGY (2009)
Bevacizumab for recurrent malignant gliomas - Efficacy, toxicity, and patterns of recurrence
A. D. Norden et al.
NEUROLOGY (2008)
Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma
Sophie de Boueard et al.
NEURO-ONCOLOGY (2007)
Approval summary: Sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma
Vicki L. Goodman et al.
CLINICAL CANCER RESEARCH (2007)
Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma
James J. Vredenburgh et al.
CLINICAL CANCER RESEARCH (2007)
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme
Morris D. Groves et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas
Marjut Puputti et al.
MOLECULAR CANCER RESEARCH (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Hypoxia-inducible factor 1α/vascular endothelial growth factor axis in astrocytomas.: Associations with microvessel morphometry, proliferation and prognosis
P Korkolopoulou et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2004)
Share Paper
